<DOC>
	<DOCNO>NCT00745290</DOCNO>
	<brief_summary>The primary objective demonstrate SKY0402 superior compare bupivacaine HCl management postoperative pain patient undergoing total knee arthroplasty .</brief_summary>
	<brief_title>A Phase 3 Study Evaluate Safety Efficacy SKY0402 Subjects Undergoing Total Knee Arthroplasty</brief_title>
	<detailed_description>The primary objective demonstrate superiority SKY0402 , compare bupivacaine HC1 , respect extent duration analgesic effect achieve single intraoperative administration study drug via local infiltration subject undergoing total knee arthroplasty ( TKA ) . The secondary objective evaluate additional efficacy parameter characterize safety profile SKY0402 comparison bupivacaine HCl .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>1 . Male female , â‰¥18 year age Screening Visit . 2 . Female subject : Postmenopausal , surgically sterile , willing use acceptable mean contraception least 30 day surgery include follow : hormonal contraceptive ( e.g. , oral , injectable , implantable start least 30 day study drug administration ) , effective doublebarrier method ( e.g. , condom spermicide ) , intrauterine device , lifestyle personal choice abstinence , nonheterosexual lifestyle , strictly monogamous relationship partner vasectomy . 3 . Scheduled undergo primary unilateral TKA general spinal anesthesia . 4 . American Society Anesthesiology ( ASA ) Physical Classification System class 14 . 5 . Able willing comply study visit procedure . 6 . Able speak , read , understand language inform consent form , study questionnaire , instrument use collect subjectreported outcome , order enable accurate appropriate response pain scale require study assessment . 7 . Willing capable provide write informed consent . 1 . Pregnancy , nursing , plan become pregnant study within one month dosing . 2 . Use following medication within time specify surgery : Longacting opioid medication within 3 day . Any opioid medication within 24 hour . 3 . Concurrent painful physical condition concurrent surgery may require analgesic treatment postoperative period pain strictly relate surgical site administer study drug ( e.g. , significant pain joint , chronic neuropathic pain , concurrent contralateral TKA , concurrent foot surgery , etc . ) , potential confound postoperative study assessment . 4 . Body weight less 60 kilogram ( ~132 pound ) . 5 . Contraindication paincontrol agent plan postoperative use ( e.g. , acetaminophen , morphine , oxycodone , ketorolac ) . 6 . Contraindication epinephrine , concurrent administration ergottype drug , monoamine oxidase ( MAO ) inhibitor antidepressant triptoline imipramine type , condition production exacerbation tachycardia could prove fatal ( e.g. , poorly control thyrotoxicosis severe heart disease ) , pathological condition might aggravate effect epinephrine . 7 . Administration investigational drug within 30 day 5 elimination halflives investigational drug , whichever longer , prior study drug administration , plan administration another investigational product procedure subject 's participation study . 8 . Suspected , know addiction abuse illicit drug ( ) , prescription medicine ( ) , alcohol within past 2 year . 9 . Uncontrolled anxiety , schizophrenia , psychiatric disorder , opinion Investigator , may interfere study assessment compliance . 10 . Current historical evidence clinically significant disease condition , opinion Investigator , may increase risk surgery complicate subject 's postoperative course . 11 . Significant medical condition laboratory result , opinion Investigator , indicate increase vulnerability study drug procedure , expose subject unreasonable risk result participate clinical trial , : debilitating disease , acute illness , hypotension , partial complete conduction block , impaired cardiac function , untreated hypertension , advance arteriosclerotic heart disease , cerebral vascular insufficiency , preexist abnormal neurological neuromuscular disease ( e.g. , epilepsy , myasthenia gravis ) , advance liver disease , severe renal impairment , advanced diabetes , comorbid condition associate immunocompromised status , blood dyscrasia , HIV/AIDS , recent chemotherapy . In addition , subject ineligible receive study drug meet follow criterion surgery : 12 . Any clinically significant event condition uncover surgery ( e.g. , excessive bleeding ) , occur study drug administration , might render subject medically unstable complicate subject 's postoperative course .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Pain</keyword>
	<keyword>Analgesia</keyword>
</DOC>